Fiduciary Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,326
Closed -$434K 63
2025
Q4
$434K Sell
1,326
-30
-2% -$9.52K 0.18% 49
2025
Q3
$383K Sell
1,356
-116
-8% -$33.6K 0.16% 54
2025
Q2
$411K Buy
1,472
+573
+64% +$162K 0.39% 34
2025
Q1
$280K Buy
+899
New +$265K 0.24% 29

Other funds holding AMGN

Fiduciary Wealth Partners's AMGN Position: Q1 2026 in Review

Fiduciary Wealth Partners sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,326 shares — an estimated $434K sold.

Fiduciary Wealth Partners first reported a position in AMGN in Q1 2025 and held it in 4 quarters. The position peaked at $434K in Q4 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fiduciary Wealth Partners reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Fiduciary Wealth Partners sold 1,326 Amgen shares in Q1 2026, an estimated $434K.
  • Fiduciary Wealth Partners first reported a position in Amgen in Q1 2025 and held it in 4 quarters.
  • Fiduciary Wealth Partners's Amgen position peaked at $434K in Q4 2025.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fiduciary Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.